Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 5
2009 3
2010 1
2011 3
2012 1
2013 1
2014 3
2015 4
2016 2
2017 2
2018 3
2019 9
2020 6
2021 9
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Brunet M, et al. Among authors: vethe nt. Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640. Ther Drug Monit. 2019. PMID: 31045868 Review.
Nytt verktøy for tolkning av farmakogenetiske analyser.
Tuv SS, Spigset O, Jensen E, Vethe NT, Nordal K. Tuv SS, et al. Among authors: vethe nt. Tidsskr Nor Laegeforen. 2023 Sep 22;143(13). doi: 10.4045/tidsskr.23.0496. Print 2023 Sep 26. Tidsskr Nor Laegeforen. 2023. PMID: 37753760 Free article. Norwegian. No abstract available.
Drug target molecules to guide immunosuppression.
Bergan S, Bremer S, Vethe NT. Bergan S, et al. Among authors: vethe nt. Clin Biochem. 2016 Mar;49(4-5):411-8. doi: 10.1016/j.clinbiochem.2015.10.001. Epub 2015 Oct 8. Clin Biochem. 2016. PMID: 26453533 Review.
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ. Bergan S, et al. Among authors: vethe nt. Ther Drug Monit. 2021 Apr 1;43(2):150-200. doi: 10.1097/FTD.0000000000000871. Ther Drug Monit. 2021. PMID: 33711005 Review.
Pharmacogenetics in personalised drug therapy.
Tuv SS, Nordal K, Vethe NT, Bergan S. Tuv SS, et al. Among authors: vethe nt. Tidsskr Nor Laegeforen. 2019 May 6;139(8). doi: 10.4045/tidsskr.19.0055. Print 2019 May 7. Tidsskr Nor Laegeforen. 2019. PMID: 31062549 Free article. English, Norwegian. No abstract available.
Plasma concentration of atorvastatin metabolites correlates with low-density lipoprotein cholesterol reduction in patients with coronary heart disease.
Sverre E, Munkhaugen J, Kristiansen O, Weedon-Fekjaer H, Peersen K, Gjertsen E, Gullestad L, Bergan S, Husebye E, Vethe NT. Sverre E, et al. Among authors: vethe nt. Pharmacol Res Perspect. 2023 Jun;11(3):e01089. doi: 10.1002/prp2.1089. Pharmacol Res Perspect. 2023. PMID: 37186070 Free PMC article. Clinical Trial.
Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle Symptoms.
Lauritzen T, Munkhaugen J, Peersen K, Kristiansen O, Sverre E, Nebauer SD, Villseth M, Andersen AM, Svarstad AC, Jensen EP, Bergan S, Husebye E, Vethe NT. Lauritzen T, et al. Among authors: vethe nt. Clin Pharmacol Ther. 2023 Apr;113(4):887-895. doi: 10.1002/cpt.2844. Epub 2023 Feb 6. Clin Pharmacol Ther. 2023. PMID: 36622792 Clinical Trial.
59 results